SIGA Technologies’ antiviral drug Tecovirimat fails to improve lesion clearance in NIH-sponsored monkeypox study in Congo, sending shares plummeting Health August 15, 2024 SIGA Technologies’ antiviral drug Tecovirimat fails to improve lesion clearance in NIH-sponsored monkeypox study in Congo, sending shares plummetingOn Thursday,…